Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
337.97
-2.84 (-0.83%)
At close: Nov 13, 2026, 4:00 PM EST
339.00
+1.03 (0.30%)
After-hours: Nov 13, 2026, 7:42 PM EST

CRL Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
40.19-144.3422.2474.62486.23390.98
Depreciation & Amortization
341.88378.81324.64314.12303.87265.54
Loss (Gain) From Sale of Assets
141.54-3.380.660.96-123.41-25.03
Asset Writedown & Restructuring Costs
344.07424.08276.2341.915.820.73
Loss (Gain) on Equity Investments
-13.9424.9112.91-97.8326.7830.42
Stock-Based Compensation
80.5671.0869.8972.0573.6271.47
Provision & Write-off of Bad Debts
3.446.0614.7718.236.711.66
Other Operating Activities
-295.97-33.6743.6-37.79-7.41-17.92
Change in Accounts Receivable
-82.6435.7421.61-33.43-150.57-26.63
Change in Inventory
60.94-48.7816.8-62.3-78.52-25.16
Change in Accounts Payable
-12.282.87-14.27-20.43-2.6544.9
Change in Unearned Revenue
8.27-23.4925.13-37.3188.123.52
Change in Other Net Operating Assets
6.3547.74-79.651.09-8.9246.31
Operating Cash Flow
622.41737.65734.58683.9619.64760.8
Operating Cash Flow Growth
-16.96%0.42%7.41%10.37%-18.55%39.19%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-222.77-219.15-232.97-318.53-324.73-228.77
Cash Acquisitions
-467.25--5.48-194.79-283.39-1,293
Divestitures
176.5617.44--163.28122.69
Investment in Securities
0.09-10.97-11.19-47.55-153.73-39.02
Other Investing Activities
51.053.364.55-2.29-9.350.26
Investing Cash Flow
-462.33-209.32-245.09-563.16-607.92-1,438

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1,2281,082776.352,9526,951
Long-Term Debt Repaid
--1,349-1,494-851.68-2,933-6,243
Net Debt Issued (Repaid)
287.81-121.78-412.19-75.3219.79708.24
Issuance of Common Stock
30.440.7123.8825.625.1145.65
Repurchase of Common Stock
-324.2-360.67-119.18-24.16-38.65-40.71
Other Financing Activities
-117-54.98-43.44-11.64-48.65-40.58
Financing Cash Flow
-122.95-536.73-550.93-85.52-42.4672.6

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
2.7318.83-17.478.0425.5817.73
Net Cash Flow
39.8610.43-78.9143.27-5.113.2

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
399.63518.49501.61365.37294.91532.03
Free Cash Flow Growth
-26.49%3.37%37.29%23.89%-44.57%40.00%
Free Cash Flow Margin
10.05%12.91%12.38%8.85%7.42%15.03%
Free Cash Flow Per Share
8.1810.469.727.105.7510.35
Levered Free Cash Flow
443.24572.38489.63214.21303.66629.6
Unlevered Free Cash Flow
511.6639.28568.56299.65340.72675.8

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
102.84101.72123.45132.1100.7570.78
Cash Income Tax Paid
62.6119.64126.190.475.9175.44
Change in Working Capital
-19.3514.08-30.33-102.38-152.5542.94
SEC Filings: 10-K · 10-Q